Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (571-580 of 590) with videos related to

Pageof 59
Sort By:
The New England Journal of Medicine|December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesStephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Cardiovascular Diabetology|March 27, 2025
Cardiovascular abnormalities already occurred in newly-diagnosed patients with early-onset type 2 diabetesHong Lian, Qian Ren, Wei Liu, et al.
Diabetes/Metabolism Research and Reviews|March 19, 2019
Chinese clinical guidelines for continuous glucose monitoring (2018 edition)Yuqian Bao, Li Chen, Liming Chen, et al.
Diabetes & Metabolism|January 17, 2026
A clinical prediction model for beta cell monogenetic diabetes in Chinese patients with early-onset type 2 diabetesSiyu Sun, Siqian Gong, Tianhao Ba, et al.
Diabetologia|March 9, 2021
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled studyLinong Ji, Ying Du, Min Xu, et al.
Diabetologia|May 26, 2021
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled studyLinong Ji, Ying Du, Min Xu, et al.
Cardiovascular Diabetology|April 9, 2022
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Cell|May 30, 2025
A microbial amino-acid-conjugated bile acid, tryptophan-cholic acid, improves glucose homeostasis via the orphan receptor MRGPREJun Lin, Qixing Nie, Jie Cheng, et al.
Primary Care Diabetes|January 28, 2023
Consensus of Chinese experts on strengthening personalized prevention and treatment of type 2 diabetesBin Lu, Jianqin Sun, Lili Chen, et al.
Diabetes|September 11, 2012
A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese HansHuaixing Li, Wei Gan, Ling Lu, et al.
Pageof 59

Showing results (571-580 of 590) with videos related to

Sort By:
Pageof 59
The New England Journal of Medicine|December 17, 2025
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesStephen J Nicholls, Imre Pavo, Deepak L Bhatt, et al.
Cardiovascular Diabetology|March 27, 2025
Cardiovascular abnormalities already occurred in newly-diagnosed patients with early-onset type 2 diabetesHong Lian, Qian Ren, Wei Liu, et al.
Diabetes/Metabolism Research and Reviews|March 19, 2019
Chinese clinical guidelines for continuous glucose monitoring (2018 edition)Yuqian Bao, Li Chen, Liming Chen, et al.
Diabetes & Metabolism|January 17, 2026
A clinical prediction model for beta cell monogenetic diabetes in Chinese patients with early-onset type 2 diabetesSiyu Sun, Siqian Gong, Tianhao Ba, et al.
Diabetologia|March 9, 2021
Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled studyLinong Ji, Ying Du, Min Xu, et al.
Diabetologia|May 26, 2021
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled studyLinong Ji, Ying Du, Min Xu, et al.
Cardiovascular Diabetology|April 9, 2022
Report from the CVOT Summit 2021: new cardiovascular, renal, and glycemic outcomesOliver Schnell, Tadej Battelino, Richard Bergenstal, et al.
Cell|May 30, 2025
A microbial amino-acid-conjugated bile acid, tryptophan-cholic acid, improves glucose homeostasis via the orphan receptor MRGPREJun Lin, Qixing Nie, Jie Cheng, et al.
Primary Care Diabetes|January 28, 2023
Consensus of Chinese experts on strengthening personalized prevention and treatment of type 2 diabetesBin Lu, Jianqin Sun, Lili Chen, et al.
Diabetes|September 11, 2012
A genome-wide association study identifies GRK5 and RASGRP1 as type 2 diabetes loci in Chinese HansHuaixing Li, Wei Gan, Ling Lu, et al.
Pageof 59